| # | Drug | Count |
|---|---|---|
| 0 | BRENTUXIMAB VEDOTIN | 10 |
| 1 | CYCLOPHOSPHAMIDE | 10 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 4 | IFOSFAMIDE | 10 |
| 5 | IFOSFAMIDE FOR INJECTION | 10 |
| 6 | PREDNISONE | 10 |
| 7 | RITUXIMAB | 10 |
| 8 | VINORELBINE | 10 |
| 9 | ACETAMINOPHEN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINORELBINE | 10 | 0.0015 |
| 1 | BRENTUXIMAB VEDOTIN | 10 | 0.0010 |
| 2 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 3 | GENTAMICIN SULFATE | 9 | 0.0006 |
| 4 | IFOSFAMIDE FOR INJECTION | 10 | 0.0005 |
| 5 | IFOSFAMIDE | 10 | 0.0005 |
| 6 | CYTARABINE | 9 | 0.0002 |
| 7 | OXALIPLATIN | 9 | 0.0001 |
| 8 | ETOPOSIDE | 8 | 0.0001 |
| 9 | CISPLATIN | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 10 | 0.0010 |
| 1 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 2 | Alkylating Drug [EPC] | 11 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 10 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |
| 6 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 7 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |